首页 | 官方网站   微博 | 高级检索  
     

阿昔洛韦联合胸腺肽抗乙肝病毒疗效观察
引用本文:梅小平,熊良仕,李建,常茂华.阿昔洛韦联合胸腺肽抗乙肝病毒疗效观察[J].川北医学院学报,1998(4).
作者姓名:梅小平  熊良仕  李建  常茂华
作者单位:川北医学院附院传染科
摘    要:本文报道了阿昔洛韦联合胸腺肽对慢性乙型肝炎抗病毒疗效,阿昔洛韦10g,胸腺肽16mg静滴,每日一次,连续治疗2月,共治疗33例,治疗结束后,治疗组HBeAg阴转16例,阴转率5517%,HBV DNA阴转18例,阴转率5454%。对照组HBeAg阴转率952%(2/25),HBV DVA阴转率909%(1/25),两组比较有显著性差异(p<001),表明阿昔洛韦联合胸腺肽是一种有效、价廉、使用方便的抗乙型肝炎病毒药物。

关 键 词:阿昔洛韦  胸腺肽  抗乙肝病毒疗效

Observation Effect of Acyclovir and Thymetide on antiHBv in Patients of Chronic Hepatitis B
Mei Xiaoping,Xiong Liangshi,Li Jian,Shang Monghua.Observation Effect of Acyclovir and Thymetide on antiHBv in Patients of Chronic Hepatitis B[J].Journal of North Sichuan Medical College,1998(4).
Authors:Mei Xiaoping  Xiong Liangshi  Li Jian  Shang Monghua
Affiliation:Affiliated Hospital North Sichuan Medical College 637000
Abstract:The effects of Acyclovir and Thrmetide for antiHBV in patients with chronic hepatitis B were reported. The dosage one gram of Acyclovir and Sixteen microgram of Thymetide were injected by day for 2 month. Thirty three patients with chronic hepatitis B were administrated. At the termination of therapy. sixteen cases with HBeAg positive have been seroconversed. the negative rates for HBeAg 55.17%(16/29) and 18 cases were seronepative for HBV DNA, the HBV DNA neqotive rates were 54.54%(18/33)while in control group the negative rates for HBeAg and HBV DNA were 9.52% and 9.09%. They had obvious statistical significance(P<0 01). These results suggested that Acyclovir and Thymetide was an effective、cheap and easly used anti HBV drug.
Keywords:Acyclovir Thymetide Anti  HBV therapy
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号